Search

everythinglearnresearchcommunity

for

Search:↓

Fisetin, a type of polyphenol, may help hair grow by increasing certain protein activities in cells.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Skin treatment can lower life quality for patients with skin conditions.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

Melatonin may help manage PCOS by improving insulin sensitivity, hormone balance, and mood.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Early-stage Alopecia Areata was effectively treated in less than six months.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Higher stress levels are linked to more skin problems, especially in young women.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

PRP injections can effectively treat alopecia areata.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.